In the evolving world of non-surgical weight loss solutions, Endoscopic Sleeve Gastroplasty (ESG) stands out as a revolutionary procedure for individuals struggling with obesity. As the Founder of ALIVA Weight Loss in Central Ohio, I'm proud to be a pioneer in offering this advanced treatment. If you're searching for "ESG weight loss Ohio" or "non-surgical weight loss procedures," you've come to the right place. In this blog, I'll explore what ESG entails, its benefits, eligibility, and why ALIVA is the top choice for transformative results.
Endoscopic Sleeve Gastroplasty, often abbreviated as ESG, is a minimally invasive procedure that reduces the size of your stomach without any incisions. Using an endoscope inserted through the mouth, I place specialized sutures to reshape the stomach into a smaller, sleeve-like structure. This limits food intake, promotes satiety, and leads to significant weight loss.
ESG is ideal for patients with a BMI between 30 and 50. It's particularly effective for those in the obese category (BMI over 30), offering a permanent solution unlike temporary options. Patients can expect to lose an average of 20% of total body weight within six months, with continued progress if they follow post-procedure guidelines.
At ALIVA Weight Loss, we made history in February 2024 by becoming the first in Central Ohio and second in Ohio to perform ESG. My dedication involved nearly two years of preparation, including upgrading the Hilliard Endo Center for advanced anesthesia, rigorous training, and team development.
This pioneering spirit ensures we deliver cutting-edge care, making ALIVA a leader in "endoscopic weight loss Ohio."
The ESG procedure typically lasts 1.5 to 2.5 hours, performed under anesthesia at our accredited facility. Patients go home the same day.
For those revising prior surgeries like gastric sleeve or bypass, I offer endoscopic revisions at ALIVA to further reduce stomach size or outlet openings, helping you regain lost progress.
Not everyone qualifies for ESG. I emphasize screening for:
If you're ineligible, I'll explore alternatives like gastric balloons or medications at ALIVA.
While medications like semaglutide (Ozempic) and tirzepatide (Mounjaro) offer weight loss, they come with drawbacks. Discovery of extendin-4 in Gila monster venom, was instrumental in developing these GLP-1 based therapies. GLP-1 drugs suppress appetite but cause muscle loss, nausea, constipation, and risks like gastroparesis. Up to 75% of users quit within two years, often regaining weight.
ESG provides a one-time, procedure-based solution without ongoing injections. It's especially appealing for those who don’t want surgery and who've failed medications or prefer non-pharmacological approaches.
If you're tired of yo-yo dieting and ready for lasting change, ESG at ALIVA Weight Loss could be your answer. As Central Ohio's pioneer, I combine expertise, compassion, and comprehensive care. Schedule a consultation today at alivaweightloss.com or call us to discuss your BMI, options, and personalized plan. Don't wait—start your weight loss journey now!